Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
ACTIVE_NOT_RECRUITING
Status
Conditions
- Urothelial Carcinoma
- Bladder Cancer
Interventions
- DRUG: Ipilimumab + nivolumab
Sponsor
The Netherlands Cancer Institute
Collaborators